Healthcare services business prices a GEL 350 million bond offering
Georgia Capital PLC (the “Company” or “GCAP”) announces that JSC Georgia Healthcare Group (“GHG”), the Georgian holding company of GCAP’s healthcare services1 business, has successfully priced a GEL 350 million secured social bond offering (the “Notes”) on the Georgian market. The Notes are GEL- denominated with 5-year bullet maturity and carry a floating coupon, as determined by Tbilisi Interbank Interest Rate (Non-Cumulative Compounded Daily TIBR) plus 375 basis points. The Notes are issued at par and are rated BB- by Scope Ratings. Settlement of the transaction is expected on 17 September 2025, followed by admission to the Georgian Stock Exchange.
GHG obtained a Second-Party Opinion from Scope, confirming that its Social Bond Framework aligns with ICMA’s 2023 Social Bond Principles. Galt & Taggart and TBC Capital acted as placement agents for the issuance of the Notes. The issuance was supported by long-standing partner international financial institutions (“IFIs”) – International Finance Corporation (“IFC”), and Asian Infrastructure Investment Bank (“AIIB”) along with local banks and Pension Fund of Georgia – whose participation represents the fund’s biggest investment in a single local bond issuance since its inception.
The proceeds will be used to refinance the issuer’s existing long-term loans and to finance capital expenditures in line with the Social Bond Framework. Upon completion, the Notes will constitute the business’ sole outstanding debt.
Irakli Gilauri, Georgia Capital Chairman and CEO commented: “I am pleased that our healthcare services business has successfully completed the largest-ever GEL-denominated corporate bond placement in Georgia. The transaction received very strong support from investors, demonstrating that Georgia’s capital markets continue to develop rapidly and, thanks to the support of local investment banks, Galt & Taggart and TBC Capital, have become a significant alternative source of capital for our group. I would like to thank the management team and our long-standing partners – IFC, AIIB, and Pension Fund of Georgia – whose efficient collaboration made this transaction a success. The Notes mark another important milestone for our group and once again reaffirm our superior access to capital.”
Other News
WHO cites Georgia’s Hepatitis C elimination program as a successful example
30.07.2026.18:13
The World Health Organization’s Regional Office for Europe (WHO/Europe) has cited Georgia’s Hepatitis C elimination program as a successful example, the Georgian Health Ministry said.
According to the Ministry, the WHO 2026 Global Report on Hepatitis emphasizes Georgia’s progress and experience in how a disease can be reduced through firm political will, large-scale testing, and the provision of universal treatment.
“Georgia’s Hepatitis C elimination program has demonstrated that elimination is not merely a goal, but a truly achievable outcome. By expanding testing, ensuring access to treatment, and collaborating closely with communities, we have dramatically reduced the burden of Hepatitis C in the country.
Our experience demonstrated that any country can make progress when Hepatitis elimination becomes a national priority,” said Maia Tsereteli, Head of Division of HIV/AIDS, Hepatitis, TB and STIs at the National Center for Disease Control and Public Health (NCDC).
The Health Ministry believes this international recognition highlights Georgia’s leadership in this direction.
The WHO calls on countries in the European region to overcome barriers and draw on the experience of successful nations to achieve the elimination of viral hepatitis by 2030.